FDA 执法报告 D-0106-2027:Eagle Pharma 催产素 500 mL 产品因无菌保障不足被列为 II 级召回
FDA drug enforcement D-0106-2027: Eagle Pharma Outsourcing LLC — Lack of Assurance of Sterility
FDA 执法报告 D-0106-2027 显示,Eagle Pharma Outsourcing LLC 的催产素 30 USP 单位加入 0.9% 氯化钠 500 mL 单次使用容器产品因无菌保障不足被列为 II 级召回。
记录列出了该产品召回的分级、批号与分销范围,可用于核对产品标识及召回状态口径。
FDA drug recall enforcement report — D-0106-2027
Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "2200 Riverchase Ctr Ste 675",
"address_2": "",
"center_classification_date": "20261028",
"city": "Hoover",
"classification": "Class II",
"code_info": "Lot: OXY30-1006, Expiry: 10/10/2026.",
"country": "United States",
"distribution_pattern": "Nationwide within the U.S",
"event_id": "100073",
"initial_firm_notification": "E-Mail",
"more_code_info": "",
"openfda": {},
"postal_code": "35244-2918",
"product_description": "OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50",
"product_quantity": "5 500-mL containers",
"product_type": "Drugs",
"reason_for_recall": "Lack of Assurance of Sterility",
"recall_initiation_date": "20261008",
"recall_number": "D-0106-2027",
"recalling_firm": "Eagle Pharma Outsourcing LLC",
"report_date": "20261104",
"state": "AL",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov